My watch list
my.bionity.com  
Login  

26 Current news about the topic streptococcus pneumoniae

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Organic insect deterrent for agriculture

Biodegradable crop protection products without risks or side effects

08-Jun-2018

Traditional insecticides are killers: they not only kill pests, they also endanger bees and other beneficial insects, as well as affecting biodiversity in soils, lakes, rivers and seas. A team from the Technical University of Munich (TUM) has now developed an alternative: A biodegradable agent ...

more

image description
The end of pneumonia? New vaccine offers hope

24-Oct-2017

In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million. Better access to antibiotics and improved nutrition account for part of the decline. But scientists say it's mostly due to vaccines introduced ...

more

image description
Chronically ill, yet healthier

11-Jul-2017

The incidence of chronic inflammatory lung diseases is on the rise throughout the world. According to the World Health Organization (WHO), they will become the third leading cause of death worldwide by 2030. So far, there is no reliable therapy, which only reflects the fact that the underlying ...

more

image description
Air pollution can alter effectiveness of antibiotics

07-Mar-2017

Air pollution can change the way bacteria behave and can change their potential to cause disease Interdisciplinary research discovers new mechanism of how air pollution is detrimental to our health and well-being Developing megacities with extreme levels of air pollution are major risk factors ...

more

Pfizer receives FDA approval for Prevnar 13®

Approval for adults age 18 through 49

14-Jul-2016

Pfizer Inc. announced that Prevnar 13 ® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S. Food and Drug Administration (FDA) approval for an expanded age indication to include adults 18 through 49 years of age, in addition to the already approved indication for ...

more

image description
Improving modern vaccines - sugar polymer tails wag the protein dog

09-Mar-2016

Millions of people - particularly infants in underdeveloped countries -- suffer from the serious life threatening illnesses of meningitis, pneumonia and influenza. These are due to infection by microbes such as N. meninigitidis, S. pneumoniae and H. influenzae b. Early vaccines were based on the ...

more

Breakthrough study discovers 6 changing faces of 'global killer' bacteria

Researchers unlock vital new information to improve vaccinations against pneumococcus infection

02-Oct-2014

Every ten seconds a human being dies from Streptococcus pneumoniae infection, also known as pneumococcus, making it a leading global killer. An interdisciplinary team of researchers from the University of Leicester in collaboration with international experts have unlocked a genetic switch ...

more

image description
New method to increase survival in sepsis

27-Nov-2013

Sepsis, the body's response to severe infections, kills more people than breast cancer, prostate cancer and HIV/AIDS combined. On average, 30 percent of those diagnosed with sepsis die. A new study conducted by Jamey Marth, director of UC Santa Barbara's Center for Nanomedicine and professor of ...

more

All in one shot

A sugar polymer found on the cell surface of multiple pathogens could be key to developing a broad-spectrum vaccine

29-May-2013

Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges—one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) ...

more

Intercell and Boehringer Ingelheim Vetmedica GmbH enter into strategic partnership to develop animal vaccines

12-May-2010

Intercell AG announced that it has entered into a worldwide Option and Exclusive License Agreement under which Boehringer Ingelheim Vetmedica has the right to use certain antigens derived from Intercell’s Antigen Identification Program (AIP®) to develop animal vaccines. Under the agreement, ...

more

Page 1 From 3
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE